A Study of MK-8527 in Healthy Adult Participants (MK-8527-013)

Completed · Phase 1

Conditions studied: Healthy

In brief

The goal of this study is to learn how \[14C\]MK-8527 moves through a healthy person's body over time. Researchers will study how \[14C\]MK-8527 is absorbed by the body, broken down by the body, and how it leaves the body.

Key facts

Study ID

NCT06826989

Run by

Merck Sharp & Dohme LLC

People needed

8

Starts

2025-03-19

Expected to finish

2025-06-04

Last updated by the study team

2025-06-11

Who can join

Age: 18 and older, up to 55. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Is in good health
• Has a body mass index (BMI) of 18 to 32 kg/m\^2

You may not qualify if…

• Has a history of cancer
• Has positive tests for hepatitis B surface antigen, hepatitis C antibodies or human immunodeficiency virus

Where it is running

• Fortea CRU Madison ( 0001) — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.